Soleno Therapeutics, Inc.
$0
0%
2026-07-22 10:38:01
soleno.life
NCM: SLNO
Explore Soleno Therapeutics, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$2.76 B
Current Price
$0
52W High / Low
$89.12 / $29.43
Stock P/E
28.77
Book Value
$8.61
Dividend Yield
—
ROCE
2.98%
ROE
22.86%
Face Value
—
EPS
$1.7
Exp Qtr EPS
—
Sector
Healthcare
SLNO — Monthly Price History
Adjusted close price · Hover to see price & month
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
- Net margin remains healthy.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Valuation is rich on a P/E basis.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Vertex Pharmaceuticals Incorporated | $451.63 | 26.79 | $114.63 B | — | — | 0.24% | $507.92 / $362.5 | $76.18 |
| 2. | Regeneron Pharmaceuticals, Inc. | $675.19 | 15.81 | $69.94 B | 0.56% | 10.23% | 14.32% | $821.11 / $541 | $295.71 |
| 3. | Revolution Medicines, Inc. | $183.29 | — | $38.94 B | — | -57.28% | -54.06% | $193.82 / $34 | $8.28 |
| 4. | Alnylam Pharmaceuticals, Inc. | $271.37 | 62.78 | $36.24 B | — | 14.33% | 98.29% | $495.55 / $266.27 | $5.96 |
| 5. | Roivant Sciences Ltd. | $34.96 | — | $33.71 B | — | -21.06% | -6.85% | $37 / $10.9 | $6.28 |
| 6. | Royalty Pharma plc | $58.42 | 40.45 | $33.47 B | 1.61% | 8.21% | 12.67% | $59.44 / $34.08 | $11.22 |
| 7. | Moderna, Inc. | $59.66 | — | $23.63 B | — | -29.7% | -36.73% | $85.6 / $22.28 | $21.95 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 91.73 M | 66.02 M | 32.66 M | 0 M | 0 M | — |
| Operating Profit | 40.43 M | 22.72 M | -5.42 M | -42.78 M | -58.79 M | — |
| Net Profit | 43.36 M | 26.01 M | -4.71 M | -43.77 M | -55.98 M | — |
| EPS in Rs | 0.84 | 0.5 | -0.09 | -0.85 | -1.08 | -1.83 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 190.41 M | 0 M | 0 M | 0 M |
| Operating Profit | 14.95 M | -184.43 M | -38.67 M | -25.11 M |
| Net Profit | 20.89 M | -175.85 M | -38.99 M | -24.07 M |
| EPS in Rs | 0.4 | -3.4 | -0.75 | -0.47 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 563.83 M | 330.97 M | 180.69 M | 26.5 M |
| Total Liabilities | 113.72 M | 85.86 M | 23.18 M | 16.15 M |
| Equity | 450.12 M | 245.11 M | 157.51 M | 10.35 M |
| Current Assets | 355.81 M | 293.89 M | 171.36 M | 15.65 M |
| Current Liabilities | 61.36 M | 18.75 M | 11.51 M | 7.31 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 46.8 M | -69.1 M | -24.94 M | -20.78 M |
| Investing CF | -201.78 M | -225.68 M | 0 M | -0.01 M |
| Financing CF | 137.16 M | 213.03 M | 180.02 M | 14.09 M |
| Free CF | 46.73 M | -69.31 M | -24.94 M | -20.79 M |
| Capex | -0.07 M | -0.22 M | — | -0.01 M |
5Y Margin & Growth History
Last 5 years of annual financial statement data.
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | — | — | — | — |
| Earnings Growth % | -351.04% | -62% | — | — |
| Profit Margin % | — | — | — | — |
| Operating Margin % | — | — | — | — |
| Gross Margin % | — | — | — | — |
| EBITDA Margin % | — | — | — | — |
Dividend & Split History
Latest dividend payments and stock split events.
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2022-08-26 | 1:0.0666667 |